When FDA investigators identify potentially grave issues at a drug manufacturer's facility, the general assumption is that the company will do its best to remedy the problem. But few things rile up the agency more than a lazy investigation—a reality Indian CMO Wintac is finding out the hard way.
Wintac Limited Receives FDA Warning Letter
A year after Lupin sealed the biggest outbound acquisition by an Indian pharma major by buying US based Gavis Pharmaceuticals LLC and Novel Laboratories for $880 mn from founder & Indian American scientist Dr Veerapan Subramanian, ET NOW learns from sources that Subramanian backed Gavis Pharma LLC is now exploring options to exit its listed Indian arm Bengaluru based Wintac LtdBSE 5.49 %. ET NOW was the first to report the development.